These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18027240)

  • 1. "Smart" drug carriers: PEGylated TATp-modified pH-sensitive liposomes.
    Kale AA; Torchilin VP
    J Liposome Res; 2007; 17(3-4):197-203. PubMed ID: 18027240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environment-responsive multifunctional liposomes.
    Kale AA; Torchilin VP
    Methods Mol Biol; 2010; 605():213-42. PubMed ID: 20072884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity.
    Koren E; Apte A; Jani A; Torchilin VP
    J Control Release; 2012 Jun; 160(2):264-73. PubMed ID: 22182771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.
    Sawant RM; Hurley JP; Salmaso S; Kale A; Tolcheva E; Levchenko TS; Torchilin VP
    Bioconjug Chem; 2006; 17(4):943-9. PubMed ID: 16848401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced transfection of tumor cells in vivo using "Smart" pH-sensitive TAT-modified pegylated liposomes.
    Kale AA; Torchilin VP
    J Drug Target; 2007; 15(7-8):538-45. PubMed ID: 17671900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery.
    Ding Y; Sun D; Wang GL; Yang HG; Xu HF; Chen JH; Xie Y; Wang ZQ
    Int J Nanomedicine; 2015; 10():6199-214. PubMed ID: 26491292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes.
    Kuai R; Yuan W; Qin Y; Chen H; Tang J; Yuan M; Zhang Z; He Q
    Mol Pharm; 2010 Oct; 7(5):1816-26. PubMed ID: 20701288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-Sensitive PEGylated Liposomal Silybin: Synthesis, In Vitro and In Vivo Anti-Tumor Evaluation.
    Gheybi F; Alavizadeh SH; Rezayat SM; Hatamipour M; Akhtari J; Faridi Majidi R; Badiee A; Jaafari MR
    J Pharm Sci; 2021 Dec; 110(12):3919-3928. PubMed ID: 34418455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo study of doxorubicin-loaded cell-penetrating peptide-modified pH-sensitive liposomes: biocompatibility, bio-distribution, and pharmacodynamics in BALB/c nude mice bearing human breast tumors.
    Ding Y; Cui W; Sun D; Wang GL; Hei Y; Meng S; Chen JH; Xie Y; Wang ZQ
    Drug Des Devel Ther; 2017; 11():3105-3117. PubMed ID: 29123382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-penetrating TAT peptide in drug delivery systems: proteolytic stability requirements.
    Koren E; Apte A; Sawant RR; Grunwald J; Torchilin VP
    Drug Deliv; 2011 Jul; 18(5):377-84. PubMed ID: 21438724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.
    Mei L; Fu L; Shi K; Zhang Q; Liu Y; Tang J; Gao H; Zhang Z; He Q
    Int J Pharm; 2014 Jul; 468(1-2):26-38. PubMed ID: 24709209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced cytotoxicity of TATp-bearing paclitaxel-loaded micelles in vitro and in vivo.
    Sawant RR; Torchilin VP
    Int J Pharm; 2009 Jun; 374(1-2):114-8. PubMed ID: 19446767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV TAT peptide modifies the distribution of DNA nanolipoparticles following convection-enhanced delivery.
    MacKay JA; Li W; Huang Z; Dy EE; Huynh G; Tihan T; Collins R; Deen DF; Szoka FC
    Mol Ther; 2008 May; 16(5):893-900. PubMed ID: 18388927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The architecture of ligand attachment to nanocarriers controls their specific interaction with target cells.
    Sawant RR; Sawant RM; Kale AA; Torchilin VP
    J Drug Target; 2008 Aug; 16(7):596-600. PubMed ID: 18686130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved transfection of spleen-derived antigen-presenting cells in culture using TATp-liposomes.
    Pappalardo JS; Quattrocchi V; Langellotti C; Di Giacomo S; Gnazzo V; Olivera V; Calamante G; Zamorano PI; Levchenko TS; Torchilin VP
    J Control Release; 2009 Feb; 134(1):41-6. PubMed ID: 19059290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups.
    Torchilin VP; Levchenko TS; Lukyanov AN; Khaw BA; Klibanov AL; Rammohan R; Samokhin GP; Whiteman KR
    Biochim Biophys Acta; 2001 Apr; 1511(2):397-411. PubMed ID: 11286983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of cargoes into a murine solid tumor by a cell-penetrating peptide and cleavable poly(ethylene glycol) comodified liposomal delivery system via systemic administration.
    Kuai R; Yuan W; Li W; Qin Y; Tang J; Yuan M; Fu L; Ran R; Zhang Z; He Q
    Mol Pharm; 2011 Dec; 8(6):2151-61. PubMed ID: 21981683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers.
    Torchilin VP
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):548-58. PubMed ID: 18053612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target.
    Klibanov AL; Maruyama K; Beckerleg AM; Torchilin VP; Huang L
    Biochim Biophys Acta; 1991 Feb; 1062(2):142-8. PubMed ID: 2004104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-targeted paclitaxel delivery and enhanced penetration using TAT-decorated liposomes comprising redox-responsive poly(ethylene glycol).
    Fu H; Shi K; Hu G; Yang Y; Kuang Q; Lu L; Zhang L; Chen W; Dong M; Chen Y; He Q
    J Pharm Sci; 2015 Mar; 104(3):1160-73. PubMed ID: 25449709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.